v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balances (in shares) at Dec. 31, 2023 6,421,084        
Balances at Dec. 31, 2023 $ 1 $ 255,913 $ (242,723) $ 199 $ 13,390
Stock-based compensation expense 0 2,013 0 0 2,013
Foreign currency translation adjustments 0 0 0 (55) (55)
Net loss $ 0 0 (11,080) 0 (11,080)
Issuance of common stock upon vesting of restricted stock awards (in shares) 543        
Issuance of common stock upon vesting of restricted stock awards $ 0 0 0 0 0
Unrealized loss on available-for-sale securities $ 0 0 0 (4) (4)
Balances (in shares) at Mar. 31, 2024 6,421,627        
Balances at Mar. 31, 2024 $ 1 257,926 (253,803) 140 4,264
Balances (in shares) at Dec. 31, 2023 6,421,084        
Balances at Dec. 31, 2023 $ 1 255,913 (242,723) 199 13,390
Foreign currency translation adjustments         (27)
Net loss         (17,865)
Unrealized loss on available-for-sale securities         (2)
Balances (in shares) at Jun. 30, 2024 6,433,628        
Balances at Jun. 30, 2024 $ 1 259,913 (260,588) 170 (504)
Balances (in shares) at Mar. 31, 2024 6,421,627        
Balances at Mar. 31, 2024 $ 1 257,926 (253,803) 140 4,264
Stock-based compensation expense 0 1,951 0 0 1,951
Foreign currency translation adjustments 0 0 0 28 28
Net loss 0 0 (6,785) 0 (6,785)
Unrealized loss on available-for-sale securities $ 0 0 0 2 2
Exercise of stock options (in shares) 12,001        
Exercise of stock options $ 0 36 0 0 36
Balances (in shares) at Jun. 30, 2024 6,433,628        
Balances at Jun. 30, 2024 $ 1 259,913 (260,588) 170 (504)
Balances (in shares) at Dec. 31, 2024 8,089,565        
Balances at Dec. 31, 2024 $ 1 273,194 (282,123) 71 (8,857)
Issuance of common stock (in shares) 578,205        
Issuance of common stock $ 0 2,673 0 0 2,673
Stock-based compensation expense 0 1,947 0 0 1,947
Foreign currency translation adjustments 0 0 0 15 15
Net loss $ 0 0 (751) 0 (751)
Balances (in shares) at Mar. 31, 2025 8,667,770        
Balances at Mar. 31, 2025 $ 1 277,814 (282,874) 86 (4,973)
Balances (in shares) at Dec. 31, 2024 8,089,565        
Balances at Dec. 31, 2024 $ 1 273,194 (282,123) 71 (8,857)
Foreign currency translation adjustments         78
Net loss         (8,170)
Unrealized loss on available-for-sale securities         0
Balances (in shares) at Jun. 30, 2025 9,462,071        
Balances at Jun. 30, 2025 $ 1 281,593 (290,293) 149 (8,550)
Balances (in shares) at Mar. 31, 2025 8,667,770        
Balances at Mar. 31, 2025 $ 1 277,814 (282,874) 86 (4,973)
Issuance of common stock (in shares) 794,301        
Issuance of common stock $ 0 2,412 0 0 2,412
Stock-based compensation expense 0 1,367 0 0 1,367
Foreign currency translation adjustments 0 0 0 63 63
Net loss $ 0 0 (7,419) 0 (7,419)
Unrealized loss on available-for-sale securities         0
Balances (in shares) at Jun. 30, 2025 9,462,071        
Balances at Jun. 30, 2025 $ 1 $ 281,593 $ (290,293) $ 149 $ (8,550)